Cholinergic system during the progression of Alzheimer’s disease: therapeutic implications

Galanin – 25 years with a multitalented neuropeptide

(2008) S. E. Counts et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Galanin – 25 years with a multitalented neuropeptide

(2008) S.-A. Hobson et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Galanin – 25 years with a multitalented neuropeptide

(2008) J. N. Crawley   CELLULAR AND MOLECULAR LIFE SCIENCES

The Biology of Neurotrophins, Signalling Pathways, and Functional Peptide Mimetics of Neurotrophins and their Receptors

(2008) Stephen Skaper   CNS & Neurological Disorders-Drug Targets

Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study

(2008) Rachelle S Doody et al.   LANCET

Galanin Hyperinnervation Upregulates Choline Acetyltransferase Expression in Cholinergic Basal Forebrain Neurons in Alzheimer’s Disease

(2008) Scott E. Counts et al.   Neurodegenerative Diseases

M1 Muscarinic Agonists Target Major Hallmarks of Alzheimer’s Disease – The Pivotal Role of Brain M1 Receptors

(2008) Abraham Fisher   Neurodegenerative Diseases

Insights into the interaction of sortilin with proneurotrophins: A computational approach

(2008) Alessandro Paiardini et al.   NEUROPEPTIDES

Binding of nerve growth factor to its p75 receptor in stressed cells induces selective IκB-β degradation and NF-κB nuclear translocation

(2003) Jose Miguel Cosgaya et al.   JOURNAL OF NEUROCHEMISTRY